This smallcap stock rallies 10% post-Q4 earnings: Here are key things to know

Its total income increased to ₹124.82 crore in the January-March period from ₹100.43 crore in the March quarter of FY24.

For the full fiscal 2024-25, its net profit surged 36.5% to ₹140 crore against ₹102.56 crore in 2023-24.

The Board of Directors has also recommended a final dividend of ₹11 per share (of ₹10 face value), which will take the total dividend declared for the year to ₹18 per share.

Care Ratings’ operating performance remained robust, with EBITDA climbing 64.8% to ₹47.7 crore and margins expanding to 43.2% from 32% a year ago.

“In FY25, CARE Ratings Ltd achieved its highest-ever standalone and consolidated income from operations, registering year-on-year growth of 19% and 21%, respectively. This performance reflects our steadfast commitment to quality-led growth. Our standalone ratings business continued to demonstrate strong traction, particularly in initial ratings of capital market instruments, securitisation, and bank debt,” said Mehul Pandya, Managing Director & Group CEO of Care Edge.

“The consolidated performance was further bolstered by an enhanced contribution from our non-ratings businesses, aided by a strong showing from our overseas rating subsidiaries,” Pandya further said.

Following this, shares of Care Ratings were trading 9.3% higher on Tuesday at ₹1,469.40 apiece on the National Stock Exchange. The stock has gained over 10% from its previous close.

In the last five trading days, the small-cap firm has gained 16.5%, and for a month’s period, it has surged over 27%.

Since November 13, 2024, that is six months, Care Ratings shares have advanced 6%. Year-to-date, it rose 8.2%.

The company’s market capitalisation stands at ₹4,398.23 crore.

The firm had touched its one-year high of ₹1,571 apiece on November 7, 2024, while its 52-week low of ₹921.80 was hit on August 7, 2024.